valine and ANCA-Associated Vasculitides

valine has been researched along with ANCA-Associated Vasculitides in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chanouzas, D; Dyall, L; Ferro, C; Harper, L; Morgan, MD; Moss, P; Nightingale, P	1

Trials

1 trial(s) available for valine and ANCA-Associated Vasculitides

Article	Year
Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial. Trials, 2016, 07-22, Volume: 17, Issue:1 Topics: Acyclovir; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Clinical Protocols; Cytomegalovirus; Cytomegalovirus Infections; England; Host-Pathogen Interactions; Humans; Proof of Concept Study; Prospective Studies; Research Design; Time Factors; Treatment Outcome; Valacyclovir; Valine; Viral Load; Virus Activation	2016

Article

Year

Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.

Trials, 2016, 07-22, Volume: 17, Issue:1

Topics: Acyclovir; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Clinical Protocols; Cytomegalovirus; Cytomegalovirus Infections; England; Host-Pathogen Interactions; Humans; Proof of Concept Study; Prospective Studies; Research Design; Time Factors; Treatment Outcome; Valacyclovir; Valine; Viral Load; Virus Activation

2016